Status of secondary prevention in patients undergoing coronary revascularization

Research output: Contribution to journalArticle

Abstract

Cardiologists, primary care physicians, and nurse practitioners play pivotal roles in the secondary prevention of CAD. All patients hospitalized for the treatment of CAD should undergo a comprehensive screening for cardiovascular risk factors and lifestyle behaviors, as well as an evaluation of the need for drug treatment with lipid-lowering agents, angiotensin-converting inhibitors, β blockers, and aspirin. Implementing quality assurance interventions, such as starting lipid-lowering therapy or other pharmacologic therapy before discharge, may improve subsequent management and assist managed care organizations in meeting performance measures mandated by the Health Plan Employer and Data Information Set. The establishment of systematic treatment plans for the management of risk factors after hospitalization for a coronary event or procedure also seems essential if optimal outcomes are to be achieved.

Original languageEnglish (US)
Pages (from-to)1203-1206
Number of pages4
JournalThe American Journal of Cardiology
Volume87
Issue number10
DOIs
StatePublished - May 15 2001

Fingerprint

Secondary Prevention
Lipids
Therapeutics
Drug Evaluation
Nurse Practitioners
Angiotensins
Managed Care Programs
Primary Care Physicians
Aspirin
Life Style
Hospitalization
Organizations
Health

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Status of secondary prevention in patients undergoing coronary revascularization. / Allen, Jerilyn K.; Blumenthal, Roger S; Margolis, Simeon; Young, Deborah Rohm.

In: The American Journal of Cardiology, Vol. 87, No. 10, 15.05.2001, p. 1203-1206.

Research output: Contribution to journalArticle

@article{7f7a18a12b10492dbaa0cbe8b51fba76,
title = "Status of secondary prevention in patients undergoing coronary revascularization",
abstract = "Cardiologists, primary care physicians, and nurse practitioners play pivotal roles in the secondary prevention of CAD. All patients hospitalized for the treatment of CAD should undergo a comprehensive screening for cardiovascular risk factors and lifestyle behaviors, as well as an evaluation of the need for drug treatment with lipid-lowering agents, angiotensin-converting inhibitors, β blockers, and aspirin. Implementing quality assurance interventions, such as starting lipid-lowering therapy or other pharmacologic therapy before discharge, may improve subsequent management and assist managed care organizations in meeting performance measures mandated by the Health Plan Employer and Data Information Set. The establishment of systematic treatment plans for the management of risk factors after hospitalization for a coronary event or procedure also seems essential if optimal outcomes are to be achieved.",
author = "Allen, {Jerilyn K.} and Blumenthal, {Roger S} and Simeon Margolis and Young, {Deborah Rohm}",
year = "2001",
month = "5",
day = "15",
doi = "10.1016/S0002-9149(01)01496-5",
language = "English (US)",
volume = "87",
pages = "1203--1206",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Status of secondary prevention in patients undergoing coronary revascularization

AU - Allen, Jerilyn K.

AU - Blumenthal, Roger S

AU - Margolis, Simeon

AU - Young, Deborah Rohm

PY - 2001/5/15

Y1 - 2001/5/15

N2 - Cardiologists, primary care physicians, and nurse practitioners play pivotal roles in the secondary prevention of CAD. All patients hospitalized for the treatment of CAD should undergo a comprehensive screening for cardiovascular risk factors and lifestyle behaviors, as well as an evaluation of the need for drug treatment with lipid-lowering agents, angiotensin-converting inhibitors, β blockers, and aspirin. Implementing quality assurance interventions, such as starting lipid-lowering therapy or other pharmacologic therapy before discharge, may improve subsequent management and assist managed care organizations in meeting performance measures mandated by the Health Plan Employer and Data Information Set. The establishment of systematic treatment plans for the management of risk factors after hospitalization for a coronary event or procedure also seems essential if optimal outcomes are to be achieved.

AB - Cardiologists, primary care physicians, and nurse practitioners play pivotal roles in the secondary prevention of CAD. All patients hospitalized for the treatment of CAD should undergo a comprehensive screening for cardiovascular risk factors and lifestyle behaviors, as well as an evaluation of the need for drug treatment with lipid-lowering agents, angiotensin-converting inhibitors, β blockers, and aspirin. Implementing quality assurance interventions, such as starting lipid-lowering therapy or other pharmacologic therapy before discharge, may improve subsequent management and assist managed care organizations in meeting performance measures mandated by the Health Plan Employer and Data Information Set. The establishment of systematic treatment plans for the management of risk factors after hospitalization for a coronary event or procedure also seems essential if optimal outcomes are to be achieved.

UR - http://www.scopus.com/inward/record.url?scp=0035873255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035873255&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(01)01496-5

DO - 10.1016/S0002-9149(01)01496-5

M3 - Article

C2 - 11356400

AN - SCOPUS:0035873255

VL - 87

SP - 1203

EP - 1206

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10

ER -